Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Apr;31(2):265-8.
doi: 10.1007/s00264-006-0165-0. Epub 2006 Jun 8.

De Quervain's disease: efficacy of intra-sheath triamcinolone injection

Takuya Sawaizumi  1 , Mitsuhiko Nanno, Hiromoto Ito
Affiliations

De Quervain's disease: efficacy of intra-sheath triamcinolone injection

Takuya Sawaizumi et al. Int Orthop. 2007 Apr.

Abstract
in English, Spanish

The methods and clinical outcomes of intra-sheath triamcinolone injection in the treatment of de Quervain's disease are described. We used 38 hands of 36 patients. A mixture of 1 ml of triamcinolone and 1 ml of 1% lidocaine hydrochloride was injected, with an interval of 2 weeks. The fluid was injected into one point above the induration for the first 18 hands and into two points over the extensor pollicis brevis and abductor pollicis longus tendon in the induration for hands 19-38. The efficacy rate was 89%, with the treatment results of the two-point injection better than those of the one-point injection. Recurrence was observed in ten hands, and complications in 13 hands; however, over 90% of patients were satisfied with the injection. The accurate injection of triamcinolone into the sheath of both the extensor pollicis brevis and abductor pollicis longus tendon was considered very effective for de Quervain's disease.

L’injection de triamcinolone dans la maladie de de Quervain a déjà été décrite. 38 mains sur 36 patients ont été traitées par un mélange d’1 ml de triamcinolone et 1 ml d’1% de lidocaine hydrochlorique injectées à l’intervalle de deux semaines. Le liquide a été injecté au dessus de l’induration : à deux niveaux différents en dessous pour les 18 premières mains et en deux points différents au dessus du court extenseur et de l’abducteur du pouce pour les 20 suivants. Le taux de succès a été de 89 avec deux points d’injection, taux supérieur à un point, une récidive a été observée dans 10 mains et des complications dans 13 mains. Cependant, plus de 90% des patients sont satisfaits de cette injection. En conclusion : l’injection triamcinolone dans la gaine de l’extenseur du pouce et de l’abducteur peuvent être considérés comme efficaces dans la maladie de de Quervain.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Injection methods. a For the first 18 hands the fluid was injected into one point immediately above the indurated tendon sheath in the first dorsal compartment of the wrist. b In hands 19–38 the amount of fluid was halved and injected into two points that coincided with the paths of the extensor pollicis brevis tendon and abductor pollicis brevis tendon
See this image and copyright information in PMC

References

    1. Ahuja NK, Chung KC (2004) Fritz de Quervain, MD (1868–1940) Stenosing tendovaginitis at the radial styloid process. J Hand Surg [Am] 29:1164–1170 - DOI - PubMed
    1. Bonnici AV, Spenser JD (1988) Survey of “Trigger finger” in adults. J Hand Surg [Br] 13:202–203 - DOI - PubMed
    1. De Quervain F (1895) Uber eine Form von chronischer Tendovaginitis. Corresp Blatt Schweizer Arzte 25:389–394
    1. Froimson A (1993) Tenosynovitis and tennis elbow. In: Green DP (ed) Operative hand surgery, vol. 2, 3rd edn. Churchill Livingstone, New York, pp 1989–2006
    1. Giles KW (1960) Anatomical variations affecting the surgery of de Quervain’s disease. J Bone Joint Surg Br 42:352–355 - PubMed